Peer-reviewedCC BY 4.0eBioMedicine
Genetically informed therapy for valvular heart disease: what, where, and when to target
Related
- A genetically informed investigation into the relationship between childhood maltreatment and adult health
- Mortality involving non-rheumatic valvular heart disease and atrial fibrillation in the United States : Long-term trends and implications
- Staged multi-target therapy for anti-MDA5-positive dermatomyositis-associated rapidly progressive interstitial lung disease: a case report.
- From Active Compound to Target Epithelium: Local Delivery, Preclinical Model Validity, and Clinical Endpoint Interpretation in Topical Therapy for HPV-Associated Lower Genital Tract Disease—A Narrative Review
- Valvular Heart Disease and the Importance of Inspiratory Muscle Training in Cardiovascular Rehabilitation
BibTeX
@article{mi2026genetically,
title = {{Genetically informed therapy for valvular heart disease: what, where, and when to target}},
author = {Yuze Mi and Yanggang Hong},
journal = {eBioMedicine},
year = {2026},
month = oct,
doi = {10.1016/j.ebiom.2026.106529},
url = {https://linkinghub.elsevier.com/retrieve/pii/S2352396426004135},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Genetically informed therapy for valvular heart disease: what, where, and when to target
AU - Yuze Mi
AU - Yanggang Hong
PY - 2026
DA - 2026/10/20
JO - eBioMedicine
DO - 10.1016/j.ebiom.2026.106529
UR - https://linkinghub.elsevier.com/retrieve/pii/S2352396426004135
SN - 2352-3964
ER -